Preferred Label : phenylthiohydantoin;

MeSH definition : Thiohydantoin benzene derivative.;

CISMeF synonym : 3-phenyl-2-thioxoimidazolidin-4-one;

MeSH CAS label : 4-Imidazolidinone, 3-phenyl-2-thioxo-;

Registry Number MeSH : 2010-15-3;

Codes EINECS : 217-927-3;

Is substance : O;

Details


Main resources

You can consult :

Thiohydantoin benzene derivative.

https://ansm.sante.fr/tableau-atu-rtu/xtandi-40-mg-comprime-pellicule
2021
false
true
false
France
French
guidelines for drug use
summary of product characteristics
package leaflet
administration, oral
enzalutamide
prostatic neoplasms
neoplasms, hormone-dependent
neoplasm metastasis
adult
antineoplastic agents, hormonal
enzalutamide
phenylthiohydantoin
phenylthiohydantoin

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Hormonotherapie-enzalutamide
2019
false
false
false
France
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
continuity of patient care
risk factors
patient education as topic
prostatic neoplasms, Castration-Resistant
enzalutamide
androgen antagonists
androgen receptor antagonists
antineoplastic agents, hormonal
antineoplastic agents, hormonal
administration, oral
neoplasm metastasis
Common Terminology Criteria for Adverse Events
hypertension
long qt syndrome
seizures
headache disorders
fatigue
leukopenia
neutropenia
thrombocytopenia
drug interactions
guidelines for drug use
phenylthiohydantoin
enzalutamide
enzalutamide
phenylthiohydantoin
phenylthiohydantoin
phenylthiohydantoin

---
http://conseil-scientifique.public.lu/fr/publications/oncologie/enzalutamide-mise-a-jour-2018.html
2018
false
false
false
Luxembourg
French
guidelines for drug use
administration, oral
enzalutamide
enzalutamide
prostatic neoplasms
neoplasm metastasis
antineoplastic agents, hormonal
prostatic neoplasms, Castration-Resistant
survival analysis
adult
androgen antagonists
enzalutamide
phenylthiohydantoin
phenylthiohydantoin

---
http://www.has-sante.fr/portail/jcms/c_2022075/fr/xtandi-enzalutamide-inhibiteur-de-la-voie-de-signalisation-des-recepteurs-aux-androgenes
http://www.has-sante.fr/portail/jcms/c_2022075/fr/xtandi
2015
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
administration, oral
treatment outcome
antineoplastic agents, hormonal
antineoplastic agents, hormonal
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
enzalutamide
survival analysis
insurance, health, reimbursement
androgen antagonists
androgen antagonists
enzalutamide
enzalutamide
phenylthiohydantoin
phenylthiohydantoin
phenylthiohydantoin

---
http://www.meddispar.fr/Medicaments/XTANDI-40-B-112/(type)/letter/(value)/X/(cip)/3400927432484
2014
false
false
false
France
French
drug information
administration, oral
legislation, drug
drug prescriptions
enzalutamide
anti-androgens
antineoplastic agents, hormonal
enzalutamide
phenylthiohydantoin
phenylthiohydantoin

---
https://www.ema.europa.eu/medicines/human/EPAR/Xtandi
2013
false
United Kingdom
French
English
enzalutamide
enzalutamide
drug approval
europe
treatment outcome
administration, oral
prostatic neoplasms
neoplasm metastasis
summary of product characteristics
package leaflet
syndication feed
drug interactions
pregnancy
breast feeding
phenylthiohydantoin
antineoplastic agents
antineoplastic agents
survival analysis
drug evaluation, preclinical

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.